Sequential intravesical chemotherapy with mitomycin C and adriamycin for superficial bladder tumor (preliminary report) by 福井, 巖 et al.
Title表在性膀胱腫瘍に対するMitomycin CとAdriamycinの連続膀胱内注入療法(予報)
Author(s)福井, 巖; 関根, 英明; 山田, 拓己; 木原, 和徳














関 根 英 明
山 田 拓 己
木 原 和 徳
    SEQUENTIAL INTRAVESICAL CHEMOTHERAPY WITH 
    MITOMYCIN C AND ADRIAMYCIN FOR SUPERFICIAL 
       BLADDER TUMOR (PRELIMINARY REPORT) 
 IWa0  FUKUI, Hideaki SEKINE, Takumi YAMADA and Kazunori KIHARA 
                 From the Department of Urology, Tokyo Medical nd Dental 
                            University School fMedicine 
   Intravesical hemotherapy with sequential instillation f mitomycin C and adriamycin was car-
ried  out on 19 patients with superficial bladder cancer (Ta,  T1 and Tis). Twenty milligram ofmito-
mycin C on day 1 and 40 mg of adriamycin o day 2 were instilled into the bladder, this treatment 
being repeated weekly for 5 consecutive weeks if there were no serious side ffects. The following results 
were obtained. 
   Of 16 evaluable patients, 10 patients (63%) achieved complete response and 2 patients achieved 
partial response, 4 patients howing no response. 
   In patients with high grade tumor, especially with carcinoma in situ, ahigh CR rate (6/7 or 86%) 
was achieved. 
   Chemical cystitis occurred in 10 out of 19 (53%) patients. In 5 of the 6 patients who suffered 
from severe cystitis symptoms, treatment was discontinued. However, the symptoms re olved within 
4 weeks in all patients. 
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福井 ・ほか:膀 胱腫瘍 ・MMC・ADM 625
Table4.ResultsofsequentialMMC-ADMtherapy























































































られた.す なわち,MMCに はG1期 の細胞に殺細胞
効果があるが,S-G2境界の細胞周期 の進行を阻害す
















剤 に よ る膀胱 内 注入 療 法 を施 行 した,方 法 は 第1日 に
MMC20mg,第2日 にA'DM40mgの 注 入 を 毎 週,
5週 間 く り返 した,
1.評 価 可 能]6例 中10例(63%)がCR,2例 が
PR,4例 がNCで あ った.
2.highgradeの腫 瘍,と くに 上 皮 内癌 に お い て
は7例 中CR6例 と高 い有 効 性 が 認 め られ た.
3.副 作 用 は膀 胱 炎 症 状 が19例中10例(53%)に み
られ た.こ の うち高 度 な もの は6例 で5例 では 治療 を
中 止 した が,全 例4週 以 内 に 症 状 の消 失 を み た.
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